DPHARM: Disruptive Innovations

TRYAL is proud to sponsor, exhibit, and present at DPHARM 2023. Meet us at Booth 69 to discuss how we can build your eConsent, eCOA, and Home Healthcare solutions faster and more efficiently than any vendor currently on the market.

To learn more about how AI is advancing eClinical innovation, don't miss Shae Wilkins' presentation:

AI with Impact:  Real-world Approaches to Making AI Work in Clinical Trials

Thursday, September 21

12:25 pm – 12:35 pm Shae Wilkins, CEO, TRYAL

AI has proven its ability to accelerate innovation in drug discovery. However, the speed of innovation has not been matched by the speed of execution in clinical studies. As AI is applied to clinical research technology in the coming years, it’s important that we adopt a framework for applying AI where it can deliver on the promises of automation, cost reduction, regulatory best practices and improved quality while avoiding the potential for increased burden and safety issues.

• Ensure that you understand AI’s capacity to accelerate trial operations but also how if used improperly it could add work and potentially impact safety

• Understand how to identify problems that are well suited for AI in clinical trials

• Discuss real world examples of where applying AI in clinical trials has been successful and where it can cause challenges

About DPHARM

Convening over 750 attendees, DPHARM 2023 reports on the latest innovations in clinical trials driving efficiencies in clinical operations and reducing patient, sites and physician burden to participate in research.

Register for DPHARM here.

To schedule a meeting or meet us for coffee, please visit our Contact Us page.